Fierce Healthcare

Centene CEO London weighs in on state of Medicaid cuts, enhanced ACA subsidies on the Hill

Centene CEO Sarah London weighed in on the state of key policy priorities for the company, namely potential cuts to Medicaid and the expiry of enhanced subsidies for Affordable Care Act plans. London ...
Fierce Healthcare

Centene CEO says final Medicare Advantage risk adjustment rule leaves 'open questions'

The Biden administration's final rule on Medicare Advantage risk adjustment leaves plenty of concerns unresolved, Centene executives said. On the company's earnings call Tuesday morning, CEO Sarah ...
Forbes

Centene Stock Up 5% After First Loss In 13 Years, Bullish Guidance

Centene's stock has plummeted due to surging medical costs and a surprise Q2 loss. Despite new, lower 2025 guidance causing a slight pop, the company faces "hurricane level headwinds" like potential ...
Morningstar

Centene: Stock Slides as Withdrawn 2025 Guidance Adds Uncertainty to Near-Term Prospects

Centene CNC withdrew its guidance, primarily due to challenges in its individual plans, including elevated medical utilization, which is also plaguing the Medicaid market. Management quantified the ...
ProPublica

Are Trump’s Top Medicaid Regulators Ignoring Major Problems? Insurance Giant’s Tense Meeting With a Senator Adds to Growing Concern.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. This story was co-published with The Dallas Morning News. The ...